查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1285863

外泌体技术市场（外泌体类型：装载的货物[肽、siRNA、mRNA、miRNA、蛋白质、化学品和其他]和非货物） - 2023-2031年全球行业分析、规模、份额、增长、趋势和预测

Exosome Technologies Market (Exosome Type: Loaded Cargos [Peptide, siRNA, mRNA, miRNA, Protein, Chemical, and Others] and Non-cargo) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 208 Pages | 商品交期: 2-10个工作天内

价格

外显子技术市场 - 报告的范围

TMR关于全球外显子技术市场的报告研究了过去以及当前的增长趋势和机会，以获得对2023年至2031年预测期间市场指标的宝贵见解。报告提供了2017-2031年期间全球外显子技术市场的收入，考虑到2023年为基准年，2031年为预测年。报告还提供了2023年至2031年全球外显子技术市场的复合年增长率（CAGR %）。

该报告是在广泛的研究后编写的。一级研究涉及大部分的研究工作，其中分析师与关键意见领袖、行业领袖和意见制造者进行了访谈。二级研究包括参考主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解等离子体材料市场。

该报告深入研究了全球等离子体材料市场的竞争格局。在全球外显子技术市场运作的主要参与者已被确定，其中每一个都在各种属性方面进行了分析。公司概况、财务状况、最近的发展和SWOT是本报告中介绍的全球外显子技术市场参与者的属性。

目录

第一章：前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目标
  • 研究重点

第二章：假设和研究方法

第三章：执行摘要：全球市场

第四章：市场概述

  • 简介
    • 外泌体类型的定义
    • 行业演变/发展
  • 概述
  • 市场动态
    • 驱动力
    • 限制因素
    • 机会
  • 2017-2031年全球市场分析与预测
    • 市场收入预测
    • 市场容量/单位出货量预测

第五章：关键洞察力

  • 管线分析
  • 技术进步
  • COVID-19大流行对行业的影响（价值链和短期/中期/长期的影响）

第六章：全球市场分析和预测：按外显子类型分类

  • 介绍和定义
  • 主要研究结果/发展情况
  • 2017-2031年按外显子类型的市场价值预测
    • 装载的卡古斯
      • 肽
      • siRNA
      • mRNA
      • miRNA
      • 蛋白质
      • 化学制品
      • 其他
    • 非货物
  • 按外泌体类型分類的市场吸引力

第7章 ：全球市场分析和预测：按细胞来源分类

  • 介绍和定义
  • 主要发现/发展
  • 2017-2031年按细胞来源的市场价值预测
    • HEK293 细胞
    • 间充质干细胞
    • 血小板
    • 红血球细胞
    • 自然杀伤细胞
    • 其他细胞
  • 不同细胞来源的市场吸引力

第八章：全球市场分析与预测：按应用分类

  • 介绍和定义
  • 主要发现/发展
  • 2017-2031年按应用的市场价值预测
    • 治疗学
      • 肿瘤学
      • 神经退行性疾病
      • 心血管疾病
      • 传染性疾病
      • 化妆品
    • 诊断学
  • 按应用分类的市场吸引力

第九章：全球市场分析与预测：按终端用户分类

  • 介绍和定义
  • 主要发现/发展
  • 2017-2031年按终端用户的市场价值预测
    • 医疗保健供应商
    • 制药和生物技术公司
    • 其他
  • 各终端用户的市场吸引力

第十章：全球市场分析和预测：按地区划分

  • 主要发现
  • 按地区的市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 国家/地区的市场吸引力

第十一章 ：北美洲市场分析与预测

  • 简介
    • 主要发现
  • 2017-2031年按外显子类型的市场价值预测
    • 负载型外泌体
      • 肽类
      • siRNA
      • mRNA
      • miRNA
      • 蛋白质
      • 化学制品
      • 其他
    • 非货物
  • 2017-2031年按细胞来源的市场价值预测
    • HEK293细胞
    • 间充质干细胞
    • 血小板
    • 红血球细胞
    • 自然杀伤细胞
    • 其他
  • 2017-2031年按应用的市场价值预测
    • 治疗学
      • 肿瘤学
      • 神经退行性疾病
      • 心血管疾病
      • 传染性疾病
      • 化妆品
    • 诊断学
  • 2017-2031年按终端用户的市场价值预测
    • 医疗保健供应商
    • 制药和生物技术公司
    • 其他
  • 按国家分類的市场价值预测，2017 - 2031年
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按外泌体类型
    • 按细胞来源分类
    • 按应用分类
    • 按终端用户分类
    • 按国家分类

第十二章 ：欧洲市场分析和预测

  • 简介
    • 主要发现
  • 2017-2031年按外显子类型的市场价值预测
    • 负载型外泌体
      • 肽类
      • siRNA
      • mRNA
      • miRNA
      • 蛋白质
      • 化学制品
      • 其他
    • 非货物
  • 2017-2031年按细胞来源的市场价值预测
    • HEK293细胞
    • 间充质干细胞
    • 血小板
    • 红血球细胞
    • 自然杀伤细胞
    • 其他
  • 2017-2031年按应用的市场价值预测
    • 治疗学
      • 肿瘤学
      • 神经退行性疾病
      • 心血管疾病
      • 传染性疾病
      • 化妆品
    • 诊断学
  • 2017-2031年按终端用户的市场价值预测
    • 医疗保健供应商
    • 制药和生物技术公司
    • 其他
  • 按国家分類的市场价值预测，2017 - 2031年
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 市场吸引力分析
    • 按外泌体类型
    • 按细胞来源分类
    • 按应用分类
    • 按终端用户
    • 按国家分类

第13章 ：亚太地区市场分析和预测

  • 简介
    • 主要发现
  • 2017-2031年按外装体类型的市场价值预测
    • 负载型外泌体
      • 肽类
      • siRNA
      • mRNA
      • miRNA
      • 蛋白质
      • 化学制品
      • 其他
    • 非货物
  • 2017-2031年按细胞来源的市场价值预测
    • HEK293细胞
    • 间充质干细胞
    • 血小板
    • 红血球细胞
    • 自然杀伤细胞
    • 其他
  • 2017-2031年按应用的市场价值预测
    • 治疗学
      • 肿瘤学
      • 神经退行性疾病
      • 心血管疾病
      • 传染性疾病
      • 化妆品
    • 诊断学
  • 2017-2031年按终端用户的市场价值预测
    • 医疗保健供应商
    • 制药和生物技术公司
    • 其他
  • 按国家分類的市场价值预测，2017 - 2031年
    • 中国
    • 日本
    • 印度
    • 澳大利亚和新西兰
    • 亚太其他地区
  • 市场吸引力分析
    • 按外泌体类型
    • 按细胞来源分类
    • 按应用分类
    • 按终端用户
    • 按国家分类

第十四章 ：拉美市场分析和预测

  • 简介
    • 主要发现
  • 2017-2031年按外源体类型的市场价值预测
    • 负载型外泌体
      • 肽类
      • siRNA
      • mRNA
      • miRNA
      • 蛋白质
      • 化学制品
      • 其他
    • 非货物
  • 2017-2031年按细胞来源的市场价值预测
    • HEK293细胞
    • 间充质干细胞
    • 血小板
    • 红血球细胞
    • 自然杀伤细胞
    • 其他
  • 2017-2031年按应用的市场价值预测
    • 治疗学
      • 肿瘤学
      • 神经退行性疾病
      • 心血管疾病
      • 传染性疾病
      • 化妆品
    • 诊断学
  • 2017-2031年按终端用户的市场价值预测
    • 医疗保健供应商
    • 制药和生物技术公司
    • 其他
  • 按国家分類的市场价值预测，2017 - 2031年
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 市场吸引力分析
    • 按外泌体类型
    • 按细胞来源分类
    • 按应用分类
    • 按终端用户
    • 按国家分类

第15章 ：中东和非洲市场分析和预测

  • 简介
    • 主要发现
  • 2017-2031年按外源体类型的市场价值预测
    • 装载的卡哥
      • 肽类
      • siRNA
      • mRNA
      • miRNA
      • 蛋白质
      • 化学制品
      • 其他
    • 非货物
  • 2017-2031年按细胞来源的市场价值预测
    • HEK293细胞
    • 间充质干细胞
    • 血小板
    • 红血球细胞
    • 自然杀伤细胞
    • 其他
  • 2017-2031年按应用的市场价值预测
    • 治疗学
      • 肿瘤学
      • 神经退行性疾病
      • 心血管疾病
      • 传染性疾病
      • 化妆品
    • 诊断学
  • 2017-2031年按终端用户的市场价值预测
    • 医疗保健供应商
    • 制药和生物技术公司
    • 其他
  • 按国家分類的市场价值预测，2017 - 2031年
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区
  • 市场吸引力分析
    • 按外泌体类型
    • 按细胞来源分类
    • 按应用分类
    • 按终端用户
    • 按国家分类

第16章 ：竞争格局

  • 市场参与者 - 竞争矩阵（按公司的层级和规模）。
  • 按公司分类的市场占有率分析（2021年）
  • 公司简介
    • AEGLE Therapeutics
    • Aruna Bio, Inc.
    • Bio-Techne Corporation (Exosome Diagnostics, Inc.)
    • Carmine Therapeutics, Inc.
    • Codiak BioSciences, Inc.
    • Creative Biolabs
    • Danaher Corporation (Beckman Coulter, Inc.)
    • Fujifilm Holdings Corporation
    • NOVADIP Biosciences S.A.
    • OmniSpirant Limited
    • Thermo Fisher Scientific, Inc.
Product Code: TMRGL65840

Exosome Technologies Market - Scope of Report

TMR's report on the global Exosome Technologies Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Exosome Technologies Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Exosome Technologies Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Exosome Technologies market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Exosome Technologies market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Exosome Technologies market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Exosome Technologies market.

The report delves into the competitive landscape of the global Exosome Technologies market. Key players operating in the global Exosome Technologies Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Exosome Technologies Market profiled in this report.

Key Questions Answered in Global Exosome Technologies Market Report:

  • What is the sales/revenue generated by Exosome Technologies across all regions during the forecast period?
  • What are the opportunities in the global Exosome Technologies market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Exosome Technologies Market - Research Objectives and Research Approach

The comprehensive report on the global Exosome Technologies Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Exosome Technologies Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Exosome Technologies market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Exosome Technologies Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Exosome Type Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Exosome Technologies Market Analysis and Forecasts, 2017 - 2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
    • 4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Exosome Technologies Market Analysis and Forecasts, by Exosome Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Exosome Type, 2017 - 2031
    • 6.3.1. Loaded Cargos
      • 6.3.1.1. Peptide
      • 6.3.1.2. siRNA
      • 6.3.1.3. mRNA
      • 6.3.1.4. miRNA
      • 6.3.1.5. Protein
      • 6.3.1.6. Chemical
      • 6.3.1.7. Others
    • 6.3.2. Non-cargo
  • 6.4. Market Attractiveness By Exosome Type

7. Global Exosome Technologies Market Analysis and Forecasts, by Cell Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 7.3.1. HEK293 Cells
    • 7.3.2. MSCs
    • 7.3.3. Platelets
    • 7.3.4. Erythrocytes
    • 7.3.5. Natural Killer Cells
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Cell Source

8. Global Exosome Technologies Market Analysis and Forecasts, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2017 - 2031
    • 8.3.1. Therapeutics
      • 8.3.1.1. Oncology
      • 8.3.1.2. Neurodegenerative Diseases
      • 8.3.1.3. Cardiovascular Diseases
      • 8.3.1.4. Infectious Diseases
      • 8.3.1.5. Cosmetics
    • 8.3.2. Diagnostics
  • 8.4. Market Attractiveness By Application

9. Global Exosome Technologies Market Analysis and Forecasts, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2017 - 2031
    • 9.3.1. Health Care Providers
    • 9.3.2. Pharmaceutical & Biotechnology Companies
    • 9.3.3. Others
  • 9.4. Market Attractiveness By End-user

10. Global Exosome Technologies Market Analysis and Forecasts, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Exosome Technologies Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 11.2.1. Loaded Cargos
      • 11.2.1.1. Peptide
      • 11.2.1.2. siRNA
      • 11.2.1.3. mRNA
      • 11.2.1.4. miRNA
      • 11.2.1.5. Protein
      • 11.2.1.6. Chemical
      • 11.2.1.7. Others
    • 11.2.2. Non-cargo
  • 11.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 11.3.1. HEK293 Cells
    • 11.3.2. MSCs
    • 11.3.3. Platelets
    • 11.3.4. Erythrocytes
    • 11.3.5. Natural Killer Cells
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Application, 2017 - 2031
    • 11.4.1. Therapeutics
      • 11.4.1.1. Oncology
      • 11.4.1.2. Neurodegenerative Diseases
      • 11.4.1.3. Cardiovascular Diseases
      • 11.4.1.4. Infectious Diseases
      • 11.4.1.5. Cosmetics
    • 11.4.2. Diagnostics
  • 11.5. Market Value Forecast By End-user, 2017 - 2031
    • 11.5.1. Health Care Providers
    • 11.5.2. Pharmaceutical & Biotechnology Companies
    • 11.5.3. Others
  • 11.6. Market Value Forecast By Country, 2017 - 2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Exosome Type
    • 11.7.2. By Cell Source
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Exosome Technologies Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 12.2.1. Loaded Cargos
      • 12.2.1.1. Peptide
      • 12.2.1.2. siRNA
      • 12.2.1.3. mRNA
      • 12.2.1.4. miRNA
      • 12.2.1.5. Protein
      • 12.2.1.6. Chemical
      • 12.2.1.7. Others
    • 12.2.2. Non-cargo
  • 12.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 12.3.1. HEK293 Cells
    • 12.3.2. MSCs
    • 12.3.3. Platelets
    • 12.3.4. Erythrocytes
    • 12.3.5. Natural Killer Cells
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Application, 2017 - 2031
    • 12.4.1. Therapeutics
      • 12.4.1.1. Oncology
      • 12.4.1.2. Neurodegenerative Diseases
      • 12.4.1.3. Cardiovascular Diseases
      • 12.4.1.4. Infectious Diseases
      • 12.4.1.5. Cosmetics
    • 12.4.2. Diagnostics
  • 12.5. Market Value Forecast By End-user, 2017 - 2031
    • 12.5.1. Health Care Providers
    • 12.5.2. Pharmaceutical & Biotechnology Companies
    • 12.5.3. Others
  • 12.6. Market Value Forecast By Country, 2017 - 2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Exosome Type
    • 12.7.2. By Cell Source
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Exosome Technologies Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 13.2.1. Loaded Cargos
      • 13.2.1.1. Peptide
      • 13.2.1.2. siRNA
      • 13.2.1.3. mRNA
      • 13.2.1.4. miRNA
      • 13.2.1.5. Protein
      • 13.2.1.6. Chemical
      • 13.2.1.7. Others
    • 13.2.2. Non-cargo
  • 13.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 13.3.1. HEK293 Cells
    • 13.3.2. MSCs
    • 13.3.3. Platelets
    • 13.3.4. Erythrocytes
    • 13.3.5. Natural Killer Cells
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Application, 2017 - 2031
    • 13.4.1. Therapeutics
      • 13.4.1.1. Oncology
      • 13.4.1.2. Neurodegenerative Diseases
      • 13.4.1.3. Cardiovascular Diseases
      • 13.4.1.4. Infectious Diseases
      • 13.4.1.5. Cosmetics
    • 13.4.2. Diagnostics
  • 13.5. Market Value Forecast By End-user, 2017 - 2031
    • 13.5.1. Health Care Providers
    • 13.5.2. Pharmaceutical & Biotechnology Companies
    • 13.5.3. Others
  • 13.6. Market Value Forecast By Country, 2017 - 2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Exosome Type
    • 13.7.2. By Cell Source
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Exosome Technologies Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 14.2.1. Loaded Cargos
      • 14.2.1.1. Peptide
      • 14.2.1.2. siRNA
      • 14.2.1.3. mRNA
      • 14.2.1.4. miRNA
      • 14.2.1.5. Protein
      • 14.2.1.6. Chemical
      • 14.2.1.7. Others
    • 14.2.2. Non-cargo
  • 14.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 14.3.1. HEK293 Cells
    • 14.3.2. MSCs
    • 14.3.3. Platelets
    • 14.3.4. Erythrocytes
    • 14.3.5. Natural Killer Cells
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Application, 2017 - 2031
    • 14.4.1. Therapeutics
      • 14.4.1.1. Oncology
      • 14.4.1.2. Neurodegenerative Diseases
      • 14.4.1.3. Cardiovascular Diseases
      • 14.4.1.4. Infectious Diseases
      • 14.4.1.5. Cosmetics
    • 14.4.2. Diagnostics
  • 14.5. Market Value Forecast By End-user, 2017 - 2031
    • 14.5.1. Health Care Providers
    • 14.5.2. Pharmaceutical & Biotechnology Companies
    • 14.5.3. Others
  • 14.6. Market Value Forecast By Country, 2017 - 2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Exosome Type
    • 14.7.2. By Cell Source
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Exosome Technologies Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Exosome Type, 2017 - 2031
    • 15.2.1. Loaded Cargos
      • 15.2.1.1. Peptide
      • 15.2.1.2. siRNA
      • 15.2.1.3. mRNA
      • 15.2.1.4. miRNA
      • 15.2.1.5. Protein
      • 15.2.1.6. Chemical
      • 15.2.1.7. Others
    • 15.2.2. Non-cargo
  • 15.3. Market Value Forecast By Cell Source, 2017 - 2031
    • 15.3.1. HEK293 Cells
    • 15.3.2. MSCs
    • 15.3.3. Platelets
    • 15.3.4. Erythrocytes
    • 15.3.5. Natural Killer Cells
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Application, 2017 - 2031
    • 15.4.1. Therapeutics
      • 15.4.1.1. Oncology
      • 15.4.1.2. Neurodegenerative Diseases
      • 15.4.1.3. Cardiovascular Diseases
      • 15.4.1.4. Infectious Diseases
      • 15.4.1.5. Cosmetics
    • 15.4.2. Diagnostics
  • 15.5. Market Value Forecast By End-user, 2017 - 2031
    • 15.5.1. Health Care Providers
    • 15.5.2. Pharmaceutical & Biotechnology Companies
    • 15.5.3. Others
  • 15.6. Market Value Forecast By Country, 2017 - 2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Exosome Type
    • 15.7.2. By Cell Source
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. AEGLE Therapeutics
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Test Type Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Aruna Bio, Inc.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Test Type Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Bio-Techne Corporation (Exosome Diagnostics, Inc.)
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Test Type Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Carmine Therapeutics, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Test Type Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Codiak BioSciences, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Test Type Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Creative Biolabs
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Test Type Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Danaher Corporation (Beckman Coulter, Inc.)
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Test Type Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Fujifilm Holdings Corporation
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Test Type Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. NOVADIP Biosciences S.A.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Test Type Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. OmniSpirant Limited
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Test Type Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Thermo Fisher Scientific, Inc.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Test Type Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview

List of Tables

  • Table 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 02: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 03: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 04: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 06: Global Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Global Exosome Technologies Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 08: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 09: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 10: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 11: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 12: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 13: North America Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 14: North America Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 17: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 18: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 19: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 21: Europe Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 24: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 25: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 26: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 27: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 28: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 29: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 30: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 31: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 32: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 33: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 34: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 35: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 36: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 37: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Exosome Type, 2017-2031
  • Table 38: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Loaded Cargos, 2017-2031
  • Table 39: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Cell Source, 2017-2031
  • Table 40: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 41: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by Therapeutics, 2017-2031
  • Table 42: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 03: Global Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 04: Global Exosome Technologies Market (US$ Mn), by Loaded Cargos, 2017-2031
  • Figure 05: Global Exosome Technologies Market (US$ Mn), by Non-cargo, 2017-2031
  • Figure 06: Global Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 07: Global Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 08: Global Exosome Technologies Market (US$ Mn), by HEK293 Cells, 2017-2031
  • Figure 09 Global Exosome Technologies Market (US$ Mn), by MSCs, 2017-2031
  • Figure 10: Global Exosome Technologies Market (US$ Mn), by Platelets, 2017-2031
  • Figure 11: Global Exosome Technologies Market (US$ Mn), by Erythrocytes, 2017-2031
  • Figure 12: Global Exosome Technologies Market (US$ Mn), by Natural Killer Cells, 2017-2031
  • Figure 13: Global Exosome Technologies Market (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 15: Global Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 16: Global Exosome Technologies Market (US$ Mn), by Therapeutics, 2017-2031
  • Figure 17: Global Exosome Technologies Market (US$ Mn), by Diagnostics, 2017-2031
  • Figure 18: Global Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Global Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 20: Global Exosome Technologies Market (US$ Mn), by Health Care Providers, 2017-2031
  • Figure 21: Global Exosome Technologies Market (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017-2031
  • Figure 22: Global Exosome Technologies Market (US$ Mn), by Others, 2017-2031
  • Figure 23: Global Exosome Technologies Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 24: Global Exosome Technologies Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 25: North America Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 26: North America Exosome Technologies Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 27: North America Exosome Technologies Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 28: North America Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 29: North America Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 30: North America Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 31: North America Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 32: North America Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 33: North America Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 34: North America Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 35: North America Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Europe Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Europe Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 38: Europe Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 39: Europe Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 40: Europe Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 41: Europe Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 42: Europe Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 43: Europe Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 44: Europe Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 45: Europe Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 46: Europe Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 47: Asia Pacific Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 48: Asia Pacific Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 49: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 50: Asia Pacific Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 51: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 52: Asia Pacific Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 53: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 54: Asia Pacific Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 55: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 56: Asia Pacific Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 57: Asia Pacific Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Latin America Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Latin America Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 60: Latin America Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Latin America Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 62: Latin America Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 63: Latin America Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 64: Latin America Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 65: Latin America Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 66: Latin America Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 67: Latin America Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 68: Latin America Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 69: Middle East & Africa Exosome Technologies Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 70: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 71: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 72: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Exosome Type, 2022 and 2031
  • Figure 73: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Exosome Type, 2023-2031
  • Figure 74: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Cell Source, 2022 and 2031
  • Figure 75: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Cell Source, 2023-2031
  • Figure 76: Middle East & Africa Exosome Technologies Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 77: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 78: Middle East & Africa Exosome Technologies Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 79: Middle East & Africa Exosome Technologies Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 80: Global Exosome Technologies Market Share Analysis, by Company, 2022